Salimian, Samaneh
Moghaddam, Nima
Deyell, Marc W.
Virani, Sean A.
Bennett, Matthew T.
Krahn, Andrew D.
Andrade, Jason G.
Hawkins, Nathaniel M. http://orcid.org/0000-0003-1286-2014
Article History
Received: 3 August 2022
Accepted: 28 October 2022
First Online: 3 November 2022
Declarations
:
: Financial interests: JA received grants and personal fees from Medtronic, Bayer, BMS-Pfizer, Servier; grants from Baylis; personal fees from Biosense-Webster. SS received salary support for quality improvement from Novartis, MD received grants and personal fees from Biosense Webster, personal fees from Medtronic, Bayer, BMS-Pfizer and Abbott, and NH received speakers’ fees from Novartis.
: After discussion with the Research Ethics Board the study was exempted from further review since quality improvement activities are exempt under article 2.5 of TCPS2, the overarching ethical framework for research involving human participants in Canada.